Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 20.9B | 19.8B | 21.9B | 21.7B |
Cost of revenue | 10.6B | 9.7B | 10.4B | 10.4B |
Gross profit | 10.3B | 10.1B | 11.5B | 11.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 5.9B | 5.5B | 5.7B | 5.5B |
Other operating expenses | — | — | — | — |
Operating income | 4.4B | 4.6B | 5.7B | 5.8B |
Non operating interest income | ||||
Income | 104M | 111M | 119M | 135M |
Expense | 212M | 217M | 240M | 238M |
Other income expense | 274M | 210M | 224M | -554M |
Pretax income | 4.5B | 4.7B | 5.8B | 5.1B |
Tax provision | 895M | 868M | 1.2B | 1.2B |
Net income | 3.6B | 3.8B | 4.7B | 4.0B |
Basic EPS | — | 1.6 | 1.9 | 1.7 |
Diluted EPS | — | 1.5 | 1.9 | 1.6 |
Basic average shares | — | 2.3B | 2.4B | 2.4B |
Diluted average shares | — | 2.4B | 2.5B | 2.5B |
EBITDA | 5.5B | 5.6B | 6.8B | 6.1B |
Net income from continuing op. | 3.6B | 3.8B | 4.7B | 4.0B |
Minority interests | -11M | -23M | -29M | -28M |
Preferred stock dividends | — | — | — | — |